CTIS2024-510727-19-00进行中（未招募）1 期
A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects with Crohn's Disease - M14-327
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Participant must have completed Study M13-740 through Week 52., If female, participant must be postmenopausal, surgically sterile or on using a birth control method.
排除标准
- •For any reason participant is considered by the investigator to be an unsuitable candidate, Female participant with a positive pregnancy test at Baseline or who is considering becoming pregnant during the study., Participant is not in compliance with prior and concomitant medication requirements and procedures throughout Study M13-740.
研究者
相似试验
进行中（未招募）
1 期
A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects with Crohn's DiseaseMedDRA version: 20.0Level: LLTClassification code 10013099Term: Disease CrohnsSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's DiseaseEUCTR2015-003759-23-SKAbbVie Deutschland GmbH & Co. KG210
进行中（未招募）
1 期
A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects with Crohn's DiseaseMedDRA version: 20.0Level: LLTClassification code 10013099Term: Disease CrohnsSystem Organ Class: 100000004856Crohn's DiseaseEUCTR2015-003759-23-GBAbbVie Deutschland GmbH & Co. KG210
进行中（未招募）
1 期
A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects with Crohn's DiseaseMedDRA version: 20.0Level: LLTClassification code 10013099Term: Disease CrohnsSystem Organ Class: 100000004856Crohn's DiseaseEUCTR2015-003759-23-NOAbbVie Deutschland GmbH & Co. KG210
进行中（未招募）
1 期
A Phase 2, Multicenter, Open-Label Extension (OLE) Study with ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 Phase 2 Randomized Controlled Trial (RCT)Psoriatic ArthritisEUCTR2014-005527-27-DEAbbVie Deutschland GmbH & Co. KG220
进行中（未招募）
1 期
A Phase 2, Multicenter, Open-Label Extension (OLE) Study with ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 Phase 2 Randomized Controlled Trial (RCT)Psoriatic ArthritisMedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 100000004859EUCTR2014-005527-27-ITABBVIE DEUTSCHLAND GMBH & CO. KG168